Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment ...

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting ...

WELLESLEY, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CLYM), announced today it will present and host investor ...

Recordati today announces an agreement with Sanofi to acquire the global rights to Enjaymo® (sutimlimab), a biologic ...

The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.

Under the deal announced Friday, the Italian pharma will make an upfront payment of $825 million to Sanofi for global rights ...

Italian pharma major Recordati saw its shares rise more than 5% to 52.00 euros in early trading, as it announced a deal to ...

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government's Advanced Research Projects Agency for Health (ARPA-H) to develop a ...

Those vaccinated had either one or two doses of Jynneos, the mpox vaccine. Comparing antibody and T-cell responses at the ...

A new lung cancer treatment that UVA doctors helped develop has been approved by the Food and Drug Administration.

Brazos, a two-year-old Asian elephant at the Fort Worth Zoo, may help cure a fatal viral infection killing young elephants in the wild and in captivity. Brazos was recently vaccinated with a ...